Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bond

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Circulation|July 23, 2003
Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factorMarkus Flesch, Anje Höper, Louis Dell'Italia, et al.
Frontiers in Cardiovascular Medicine|February 23, 2024
Convergent approach to persistent atrial fibrillation ablation: long-term single-centre safety and efficacyAlexander Carpenter, Laura M K Pannell, Syed I A Rizvi, et al.
Circulation. Arrhythmia and Electrophysiology|November 20, 2012
Activation of glibenclamide-sensitive ATP-sensitive K+ channels during β-adrenergically induced metabolic stress produces a substrate for atrial tachyarrhythmiaShang-Jin Kim, Haifei Zhang, Igor Khaliulin, et al.
Cancer Research|September 5, 2019
Correction: Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate CancerChuandong Geng, Kimal Rajapakshe, Shrijal S Shah, et al.
Cancer Research|October 3, 2014
Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancerChuandong Geng, Kimal Rajapakshe, Shrijal S Shah, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammationRichard W Chapman, Michael Minnicozzi, Chander S Celly, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2013
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnoverChuandong Geng, Bin He, Limei Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonistsYounong Yu, Michael P Dwyer, Jianping Chao, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonistMichael P Dwyer, Younong Yu, Jianping Chao, et al.
Physical Review Letters|May 2, 2015
Evidence of lensing of the cosmic microwave background by dark matter halosMathew Madhavacheril, Neelima Sehgal, Rupert Allison, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Circulation|July 23, 2003
Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factorMarkus Flesch, Anje Höper, Louis Dell'Italia, et al.
Frontiers in Cardiovascular Medicine|February 23, 2024
Convergent approach to persistent atrial fibrillation ablation: long-term single-centre safety and efficacyAlexander Carpenter, Laura M K Pannell, Syed I A Rizvi, et al.
Circulation. Arrhythmia and Electrophysiology|November 20, 2012
Activation of glibenclamide-sensitive ATP-sensitive K+ channels during β-adrenergically induced metabolic stress produces a substrate for atrial tachyarrhythmiaShang-Jin Kim, Haifei Zhang, Igor Khaliulin, et al.
Cancer Research|September 5, 2019
Correction: Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate CancerChuandong Geng, Kimal Rajapakshe, Shrijal S Shah, et al.
Cancer Research|October 3, 2014
Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancerChuandong Geng, Kimal Rajapakshe, Shrijal S Shah, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammationRichard W Chapman, Michael Minnicozzi, Chander S Celly, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2013
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnoverChuandong Geng, Bin He, Limei Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonistsYounong Yu, Michael P Dwyer, Jianping Chao, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonistMichael P Dwyer, Younong Yu, Jianping Chao, et al.
Physical Review Letters|May 2, 2015
Evidence of lensing of the cosmic microwave background by dark matter halosMathew Madhavacheril, Neelima Sehgal, Rupert Allison, et al.
Pageof 4